FRANKLIN LAKES, N.J.,
Nov. 20, 2017 /PRNewswire/ -- The
Board of Directors of BD (Becton, Dickinson and Company) (NYSE:
BDX) has declared a quarterly dividend of $0.75 cents per common share, an increase of 2.7
percent from the previous quarter. The dividend will be
payable on December 29, 2017 to
holders of record on December 8,
2017. The indicated annual dividend rate for fiscal
year 2018 is $3.00 per share.
"We are very pleased with our strong fiscal 2017 results, which
demonstrate our ability to overcome multiple headwinds and deliver
on our commitments. We enter fiscal 2018 with continued
momentum in our core and look forward to the successful closing of
the C.R. Bard acquisition. We believe there are significant
opportunities ahead for BD as we continue to deliver innovative
healthcare solutions to our customers and their patients around the
world," said Vincent A. Forlenza,
Chairman and CEO. "This is the forty-sixth consecutive fiscal
year in which we have raised our dividend. This increase
reflects our confidence in our long-term outlook, as well as our
ongoing commitment to create value and return capital to our
shareholders."
About BD
BD is a global medical technology company that is advancing the
world of health by improving medical discovery, diagnostics and
the delivery of care. BD leads in patient and health care worker
safety and the technologies that enable medical research and
clinical laboratories. The company provides innovative solutions
that help advance medical research and genomics, enhance the
diagnosis of infectious disease and cancer, improve medication
management, promote infection prevention, equip surgical and
interventional procedures, and support the management of diabetes.
The company partners with organizations around the world to address
some of the most challenging global health issues. BD has more than
40,000 associates across 50 countries who work in close
collaboration with customers and partners to help enhance outcomes,
lower health care delivery costs, increase efficiencies, improve
health care safety and expand access to health. For more
information on BD, please visit bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique Dolecki, Investor Relations
– 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-board-increases-dividend-300559604.html
SOURCE BD (Becton, Dickinson and Company)